BioLargo, Inc.
BLGO
$0.2639
-$0.0002-0.08%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 45.21% | 12.25% | -19.52% | 21.66% | 34.62% |
| Total Depreciation and Amortization | 37.31% | 93.20% | 376.92% | 504.44% | 548.39% |
| Total Amortization of Deferred Charges | -100.00% | -100.00% | -100.00% | -82.35% | -61.11% |
| Total Other Non-Cash Items | -22.44% | 58.48% | 34.44% | -1.90% | -39.48% |
| Change in Net Operating Assets | -141.08% | 105.24% | -413.04% | -299.60% | 51.47% |
| Cash from Operations | 44.36% | 79.05% | -10.57% | 14.37% | 38.54% |
| Capital Expenditure | -220.27% | -429.29% | -350.52% | -76.38% | -167.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -220.27% | -429.29% | -350.52% | -76.38% | -148.02% |
| Total Debt Issued | -35.00% | -- | -35.00% | -35.00% | -- |
| Total Debt Repaid | 151.19% | 140.70% | 140.74% | -3.85% | -154.55% |
| Issuance of Common Stock | 23.94% | -20.48% | -27.75% | -17.66% | -32.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -97.94% | -78.64% | 207.78% | 615.56% | 1,600.00% |
| Cash from Financing | -20.04% | -34.40% | -0.98% | 17.77% | 7.40% |
| Foreign Exchange rate Adjustments | -387.50% | -122.22% | 18.75% | -276.47% | 132.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -52.65% | -49.34% | -53.19% | 89.88% | 943.53% |
